Have a personal or library account? Click to login
A comparison of effectiveness of the contrast enhanced computed tomography with magnetic resonance imaging in the differential diagnosis of clear cell renal carcinoma Cover

A comparison of effectiveness of the contrast enhanced computed tomography with magnetic resonance imaging in the differential diagnosis of clear cell renal carcinoma

Open Access
|Jun 2025

References

  1. Roussel E, Campi R, Amparore D, Bertolo R, Carbonara U, Erdem S, et al. Expanding the role of ultrasound for the characterization of renal masses. J Clin Med 2022; 11: 1112. doi: 10.3390/jcm11041112
  2. Roussel E, Capitanio U, Kutikov A, Oosterwijk E, Pedrosa I, Rowe SP, et al. Novel imaging methods for renal mass characterization: a collaborative review. Eur Urol 2022; 81: 476-88. doi: 10.1016/j.eururo.2022.01.040
  3. Schieda N, Krishna S, Pedrosa I, Kaffenberger SD, Davenport MS, Silverman SG. Active surveillance of renal masses: the role of radiology. Radiology 2022; 302: 11-24. doi: 10.1148/radiol.2021204227
  4. Johnson DC, Vukina J, Smith AB, Meyer AM, Wheeler SB, Kuo TM, et al. Preoperatively misclassified, surgically removed benign renal masses: a systematic review of surgical series and United States population level burden estimate. J Urol 2015; 193: 30-5. doi: 10.1016/j.juro.2014.07.102
  5. Campbell SC, Clark PE, Chang SS, Karam JA, Souter L, Uzzo RG. Renal mass and localized renal cancer: evaluation, management, and followup: AUA Guideline: Part I. J Urol 2021; 206: 199-208. doi: 10.1097/JU.0000000000001911
  6. Chawla SN, Crispen PL, Hanlon AL, Greenberg RE, Chen DY, Uzzo RG. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol 2006; 175: 425-31. doi: 10.1016/S0022-5347(05)00148-5
  7. Bahadoram S, Davoodi M, Hassanzadeh S, Bahadoram M, Barahman M, Mafakher L. Renal cell carcinoma: an overview of the epidemiology, diagnosis, and treatment. G Ital Nefrol 2022; 39: 2022-vol3. PMID: 35819037
  8. Kay FU, Pedrosa I. Imaging of solid renal masses. Urol Clin North Am 2018; 45: 311-30. doi: 10.1016/j.ucl.2018.03.013
  9. Warshauer DM, McCarthy SM, Street L, Bookbinder MJ, Glickman MG, Richter J, et al. Detection of renal masses: sensitivities and specificities of excretory urography/linear tomography, US, and CT. Radiology 1988; 169: 363-5. doi: 10.1148/radiology.169.2.3051112
  10. Krishna S, Leckie A, Kielar A, Hartman R, Khandelwal A. Imaging of renal cancer. Semin Ultrasound CT MR 2020; 41: 152-69. doi: 10.1053/j. sult.2019.12.004
  11. Elstob A, Gonsalves M, Patel U. Diagnostic modalities. Int J Surg 2016; 36: 504-12. doi: 10.1016/j.ijsu.2016.06.005
  12. Muglia VF, Prando A. Renal cell carcinoma: histological classification and correlation with imaging findings. Radiol Bras 2015; 48: 166-74. doi: 10.1590/0100-3984.2013.1927
  13. Blachura T, Matusik PS, Kowal A, Radzikowska J, Jarczewski JD, Skiba Ł, et al. Diagnostic accuracy of the Clear Cell Likelihood Score and selected MRI parameters in the characterization of indeterminate renal masses-a single-institution study. Abdom Radiol 2024; 49: 3893-901. doi: 10.1007/s00261-024-04484-5
  14. Jonisch AI, Rubinowitz AN, Mutalik PG, Israel GM. Can high-attenuation renal cysts be differentiated from renal cell carcinoma at unenhanced CT? Radiology 2007; 243: 445-50. doi: 10.1148/radiol.2432060559
  15. Badri AV, Waingankar N, Edwards K, Kutikov A, Parsons RB, Chen DY, et al. Non-contrast imaging characteristics of papillary renal cell carcinoma: implications for diagnosis and subtyping. Can J Urol 2019; 26: 9916-21. PMID: 31629440
  16. Pan H, Ye L, Zhu Q, Yang Z, Hu M. The effect of the papillary renal cell carcinoma subtype on oncological outcomes. Sci Rep 2020; 10: 21073. doi: 10.1038/s41598-020-78174-9.
  17. Abdelmegeed SA, Farok HM, Refaat MM, Eldiasty TA. Role of multidetector ct in quantitative enhancement-washout analysis of solid renal masses. Egypt J Radiol Nucl Med 2021; 52: 274. doi: 10.1186/s43055-021-00650-7
  18. O’Connor SD, Pickhardt PJ, Kim DH, Oliva MR, Silverman SG. Incidental finding of renal masses at unenhanced CT: prevalence and analysis of features for guiding management. AJR Am J Roentgenol 2011; 197: 139-45. doi: 10.2214/AJR.10.5920
  19. Krishna S, Murray CA, McInnes MD, Chatelain R, Siddaiah M, Al-Dandan O, et al. CT imaging of solid renal masses: pitfalls and solutions. Clin Radiol 2017; 72: 708-21. doi: 10.1016/j.crad.2017.05.003
  20. Zhang J, Lefkowitz RA, Ishill NM, Wang L, Moskowitz CS, Russo P, et al. Solid renal cortical tumors: differentiation with CT. Radiology 2007; 244: 494-504. doi: 10.1148/radiol.2442060927
  21. Giambelluca D, Pellegrino S, Midiri M, Salvaggio G. The “central stellate scar” sign in renal oncocytoma. Abdom Radiol 2019; 44: 1942-3. doi: 10.1007/s00261-019-01899-3
  22. Campbell N, Rosenkrantz AB, Pedrosa I. MRI phenotype in renal cancer: is it clinically relevant? Top Magn Reson Imaging 2014; 23: 95-115. doi: 10.1097/RMR.0000000000000019
  23. Sasaguri K, Takahashi N. CT and MR imaging for solid renal mass characterization. Eur J Radiol 2018; 99: 40-54. doi: 10.1016/j.ejrad.2017.12.008
  24. Pierorazio PM, Hyams ES, Tsai S, Feng Z, Trock BJ, Mullins JK, et al. Multiphasic enhancement patterns of small renal masses (≤4 cm) on preoperative computed tomography: utility for distinguishing subtypes of renal cell carcinoma, angiomyolipoma, and oncocytoma. Urology 2013; 81: 1265-71. doi: 10.1016/j.urology.2012.12.049
  25. Bazzocchi MV, Zilioli C, Gallone VI, Commisso C, Bertolotti L, Pagnini F, et al. The role of CT imaging in characterization of small renal masses. Diagnostics 2023; 13: 334. doi: 10.3390/diagnostics13030334
  26. Kopp RP, Aganovic L, Palazzi KL, Cassidy FH, Sakamoto K, Derweesh IH. Differentiation of clear from non-clear cell renal cell carcinoma using CT washout formula. Can J Urol 2013; 20: 6790-7. PMID: 23783049
  27. Sun MR, Ngo L, Genega EM, Atkins MB, Finn ME, Rofsky NM, et al. Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes - correlation with pathologic findings. Radiology 2009; 250: 793-802. doi: 10.1148/radiol.2503080995
  28. Bird VG, Kanagarajah P, Morillo G, Caruso DJ, Ayyathurai R, Leveillee R, et al. Differentiation of oncocytoma and renal cell carcinoma in small renal masses (< 4 cm): the role of 4-phase computerized tomography. World J Urol 2011; 29: 787-92. doi: 10.1007/s00345-010-0586-7
  29. Xie P, Yang Z, Yuan Z. Lipid-poor renal angiomyolipoma: differentiation from clear cell renal cell carcinoma using wash-in and washout characteristics on contrast-enhanced computed tomography. Oncol Lett 2016; 11: 2327-31. doi: 10.3892/ol.2016.4214
  30. Posada Calderon L, Eismann L, Reese SW, Reznik E, Hakimi AA. Advances in imaging-based biomarkers in renal cell carcinoma: a critical analysis of the current literature. Cancers 2023; 15: 354. doi: 10.3390/cancers15020354
  31. Baldari D, Capece S, Mainenti PP, Tucci AG, Klain M, Cozzolino I, et al. Comparison between computed tomography multislice and high-field magnetic resonance in the diagnostic evaluation of patients with renal masses. Quant Imaging Med Surg 2015; 5: 691-9. doi: 10.3978/j. issn.2223-4292.2015.07.03
  32. Chow WH, Dong LM, Devesa SS. Epidemiology and risk factors for kidney cancer. Nat Rev Urol 2010; 7: 245-57. doi: 10.1038/nrurol.2010.46
DOI: https://doi.org/10.2478/raon-2025-0033 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 193 - 202
Submitted on: Jan 30, 2025
|
Accepted on: Apr 30, 2025
|
Published on: Jun 16, 2025
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2025 Tomasz Blachura, Julia Radzikowska, Patrycja S. Matusik, Aleksander Kowal, Jarosław D Jarczewski, Łukasz Skiba, Tadeusz J Popiela, Robert Chrzan, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.